These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 10445845)

  • 1. Heart-specific activation of LTK results in cardiac hypertrophy, cardiomyocyte degeneration and gene reprogramming in transgenic mice.
    Honda H; Harada K; Komuro I; Terasaki F; Ueno H; Tanaka Y; Kawamura K; Yazaki Y; Hirai H
    Oncogene; 1999 Jul; 18(26):3821-30. PubMed ID: 10445845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Casein kinase-2α1 induces hypertrophic response by phosphorylation of histone deacetylase 2 S394 and its activation in the heart.
    Eom GH; Cho YK; Ko JH; Shin S; Choe N; Kim Y; Joung H; Kim HS; Nam KI; Kee HJ; Kook H
    Circulation; 2011 May; 123(21):2392-403. PubMed ID: 21576649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic overexpression of constitutively active protein kinase C epsilon causes concentric cardiac hypertrophy.
    Takeishi Y; Ping P; Bolli R; Kirkpatrick DL; Hoit BD; Walsh RA
    Circ Res; 2000 Jun; 86(12):1218-23. PubMed ID: 10864911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An angiotensin II type 1 receptor mutant lacking epidermal growth factor receptor transactivation does not induce angiotensin II-mediated cardiac hypertrophy.
    Zhai P; Galeotti J; Liu J; Holle E; Yu X; Wagner T; Sadoshima J
    Circ Res; 2006 Sep; 99(5):528-36. PubMed ID: 16902180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The deltaC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure.
    Zhang T; Maier LS; Dalton ND; Miyamoto S; Ross J; Bers DM; Brown JH
    Circ Res; 2003 May; 92(8):912-9. PubMed ID: 12676814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial hypertrophy in transgenic mice overexpressing human interleukin 1alpha.
    Isoda K; Kamezawa Y; Tada N; Sato M; Ohsuzu F
    J Card Fail; 2001 Dec; 7(4):355-64. PubMed ID: 11782860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focal adhesion kinase governs cardiac concentric hypertrophic growth by activating the AKT and mTOR pathways.
    Clemente CF; Xavier-Neto J; Dalla Costa AP; Consonni SR; Antunes JE; Rocco SA; Pereira MB; Judice CC; Strauss B; Joazeiro PP; Matos-Souza JR; Franchini KG
    J Mol Cell Cardiol; 2012 Feb; 52(2):493-501. PubMed ID: 22056317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenic model of aldosterone-driven cardiac hypertrophy and heart failure.
    Qin W; Rudolph AE; Bond BR; Rocha R; Blomme EA; Goellner JJ; Funder JW; McMahon EG
    Circ Res; 2003 Jul; 93(1):69-76. PubMed ID: 12791709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload.
    Harris IS; Zhang S; Treskov I; Kovacs A; Weinheimer C; Muslin AJ
    Circulation; 2004 Aug; 110(6):718-23. PubMed ID: 15289381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrin-linked kinase expression is elevated in human cardiac hypertrophy and induces hypertrophy in transgenic mice.
    Lu H; Fedak PW; Dai X; Du C; Zhou YQ; Henkelman M; Mongroo PS; Lau A; Yamabi H; Hinek A; Husain M; Hannigan G; Coles JG
    Circulation; 2006 Nov; 114(21):2271-9. PubMed ID: 17088456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adiponectin is required for cardiac MEF2 activation during pressure overload induced hypertrophy.
    Dadson K; Turdi S; Hashemi S; Zhao J; Polidovitch N; Beca S; Backx PH; McDermott JC; Sweeney G
    J Mol Cell Cardiol; 2015 Sep; 86():102-9. PubMed ID: 26196305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo.
    Passier R; Zeng H; Frey N; Naya FJ; Nicol RL; McKinsey TA; Overbeek P; Richardson JA; Grant SR; Olson EN
    J Clin Invest; 2000 May; 105(10):1395-406. PubMed ID: 10811847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac raptor ablation impairs adaptive hypertrophy, alters metabolic gene expression, and causes heart failure in mice.
    Shende P; Plaisance I; Morandi C; Pellieux C; Berthonneche C; Zorzato F; Krishnan J; Lerch R; Hall MN; Rüegg MA; Pedrazzini T; Brink M
    Circulation; 2011 Mar; 123(10):1073-82. PubMed ID: 21357822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gelsolin regulates cardiac remodeling after myocardial infarction through DNase I-mediated apoptosis.
    Li GH; Shi Y; Chen Y; Sun M; Sader S; Maekawa Y; Arab S; Dawood F; Chen M; De Couto G; Liu Y; Fukuoka M; Yang S; Da Shi M; Kirshenbaum LA; McCulloch CA; Liu P
    Circ Res; 2009 Apr; 104(7):896-904. PubMed ID: 19246681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy.
    Kemi OJ; Ceci M; Wisloff U; Grimaldi S; Gallo P; Smith GL; Condorelli G; Ellingsen O
    J Cell Physiol; 2008 Feb; 214(2):316-21. PubMed ID: 17941081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac-specific overexpression of diacylglycerol kinase zeta prevents Gq protein-coupled receptor agonist-induced cardiac hypertrophy in transgenic mice.
    Arimoto T; Takeishi Y; Takahashi H; Shishido T; Niizeki T; Koyama Y; Shiga R; Nozaki N; Nakajima O; Nishimaru K; Abe J; Endoh M; Walsh RA; Goto K; Kubota I
    Circulation; 2006 Jan; 113(1):60-6. PubMed ID: 16380548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased tyrosine-phosphorylation of 55KDa proteins in beta-actin/Tec transgenic mice.
    Honda H; Mano H; Katsuki M; Yazaki Y; Hirai H
    Biochem Biophys Res Commun; 1995 Jan; 206(1):287-93. PubMed ID: 7529498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HSP75 protects against cardiac hypertrophy and fibrosis.
    Zhang Y; Jiang DS; Yan L; Cheng KJ; Bian ZY; Lin GS
    J Cell Biochem; 2011 Jul; 112(7):1787-94. PubMed ID: 21381076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiomyocyte-specific transgenic expression of lysyl oxidase-like protein-1 induces cardiac hypertrophy in mice.
    Ohmura H; Yasukawa H; Minami T; Sugi Y; Oba T; Nagata T; Kyogoku S; Ohshima H; Aoki H; Imaizumi T
    Hypertens Res; 2012 Nov; 35(11):1063-8. PubMed ID: 22763477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted disruption of Smad4 in cardiomyocytes results in cardiac hypertrophy and heart failure.
    Wang J; Xu N; Feng X; Hou N; Zhang J; Cheng X; Chen Y; Zhang Y; Yang X
    Circ Res; 2005 Oct; 97(8):821-8. PubMed ID: 16151019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.